(919) 224-8800 Contact Our Team

Free Whitepaper:

Trends and Considerations in Global Cardiovascular Drug Development

With more than 350 experimental cardiovascular agents in today’s rich biopharmaceutical pipeline, multinational trials are developing new therapies across a divergent research landscape.

To conduct successful global studies, sponsors must ensure consistency across varying regulatory requirements and standards of care as they manage trial operations country-by-country.

In this paper, you’ll learn:

  • Expert views on research pipeline and approval trends
  • Global trends in cardiovascular research
  • Operational considerations regarding international regulatory practices, patient and investigator recruitment, standards of care, technology integration and clinical supply management


Download the eBook now:

  •